December 10, 2025 at 11:18 PM
Defining Relationships Among #Tests for #KidneyTransplant Antibody-Mediated Rejection #ABMR
#VisualAbstract by @deniiseam.bsky.social
www.kireports.org/ar...
#VisualAbstract by @deniiseam.bsky.social
www.kireports.org/ar...
July 25, 2025 at 3:00 PM
Defining Relationships Among #Tests for #KidneyTransplant Antibody-Mediated Rejection #ABMR
#VisualAbstract by @deniiseam.bsky.social
www.kireports.org/ar...
#VisualAbstract by @deniiseam.bsky.social
www.kireports.org/ar...
As one of the original flozinators it so maddening to see nephrologists flozinate *instead* of using immunosuppresants, dz modifying therapies in nonDM CKD. Consider a thought experiment in transplant: proteinuria is often how we pick up ABMR & an SGLT2i is the wrong answer. Now do IgAN, SLE,C3G etc
November 10, 2025 at 2:18 PM
As one of the original flozinators it so maddening to see nephrologists flozinate *instead* of using immunosuppresants, dz modifying therapies in nonDM CKD. Consider a thought experiment in transplant: proteinuria is often how we pick up ABMR & an SGLT2i is the wrong answer. Now do IgAN, SLE,C3G etc
my latest cover with the American Journal of Transplantation!
April 7, 2025 at 5:17 PM
my latest cover with the American Journal of Transplantation!
Happy “Gotcha “ day to Avalon. 2 years with us… it’s been an adventure! Thanks to ABMR for taking care of her as a pup in rescue. #belgianmalinois #rescuedogs #caninecompanion
January 26, 2025 at 8:21 PM
Happy “Gotcha “ day to Avalon. 2 years with us… it’s been an adventure! Thanks to ABMR for taking care of her as a pup in rescue. #belgianmalinois #rescuedogs #caninecompanion
11/n At crossroads with anemia and ABMR!
How do you approach?
#ECNeph #NephSky
@DivyaveerSSNeph.bsky.social @myadla.bsky.social
How do you approach?
#ECNeph #NephSky
@DivyaveerSSNeph.bsky.social @myadla.bsky.social
December 6, 2024 at 4:26 PM
11/n At crossroads with anemia and ABMR!
How do you approach?
#ECNeph #NephSky
@DivyaveerSSNeph.bsky.social @myadla.bsky.social
How do you approach?
#ECNeph #NephSky
@DivyaveerSSNeph.bsky.social @myadla.bsky.social
Chronic active ABMR in patient with worsening proteinuria, renal function, positive DSA
*Glomerulitis (shown in image)
*Transplant glomerulopathy (shown in image)
*Peritubular capillaritis
*Diffuse C4d+ in PTCs on IF
#renalpath #transplant #pathsky #nephsky #medsky
*Glomerulitis (shown in image)
*Transplant glomerulopathy (shown in image)
*Peritubular capillaritis
*Diffuse C4d+ in PTCs on IF
#renalpath #transplant #pathsky #nephsky #medsky
April 7, 2025 at 3:50 AM
Chronic active ABMR in patient with worsening proteinuria, renal function, positive DSA
*Glomerulitis (shown in image)
*Transplant glomerulopathy (shown in image)
*Peritubular capillaritis
*Diffuse C4d+ in PTCs on IF
#renalpath #transplant #pathsky #nephsky #medsky
*Glomerulitis (shown in image)
*Transplant glomerulopathy (shown in image)
*Peritubular capillaritis
*Diffuse C4d+ in PTCs on IF
#renalpath #transplant #pathsky #nephsky #medsky
Microvascular Inflammation in TX Biopsies - As compared with pts without rejection, the hazard ratio for graft loss was 2.1 among patients with microvascular inflammation without evidence of an antibody-mediated response & 2.7 among patients with ABMR www.nejm.org/doi/full/10....
@nejm.org #nephsky
@nejm.org #nephsky
February 26, 2025 at 1:47 AM
Microvascular Inflammation in TX Biopsies - As compared with pts without rejection, the hazard ratio for graft loss was 2.1 among patients with microvascular inflammation without evidence of an antibody-mediated response & 2.7 among patients with ABMR www.nejm.org/doi/full/10....
@nejm.org #nephsky
@nejm.org #nephsky
TOP 2: Felzartamab in ABMR by Drs. Mayer, Böhmig et al.
www.nejm.org/doi/abs/10.1...
In patients with antibody-mediated rejection, felzartamab had acceptable safety and side-effect profiles.
Check out our webinar about Felzartamab!
👉 youtu.be/GhiaE5V0Pr4?...
www.nejm.org/doi/abs/10.1...
In patients with antibody-mediated rejection, felzartamab had acceptable safety and side-effect profiles.
Check out our webinar about Felzartamab!
👉 youtu.be/GhiaE5V0Pr4?...
January 15, 2025 at 6:56 PM
TOP 2: Felzartamab in ABMR by Drs. Mayer, Böhmig et al.
www.nejm.org/doi/abs/10.1...
In patients with antibody-mediated rejection, felzartamab had acceptable safety and side-effect profiles.
Check out our webinar about Felzartamab!
👉 youtu.be/GhiaE5V0Pr4?...
www.nejm.org/doi/abs/10.1...
In patients with antibody-mediated rejection, felzartamab had acceptable safety and side-effect profiles.
Check out our webinar about Felzartamab!
👉 youtu.be/GhiaE5V0Pr4?...
The ToM went to Kidney International trial. Mulley et al showed that IVIG stabilized chronic injury scores and slowed eGFR decline in patients with chronic active ABMR, without reducing DSAs, suggesting graft-level immune-modulation of fibrosis.
February 23, 2026 at 9:00 AM
The ToM went to Kidney International trial. Mulley et al showed that IVIG stabilized chronic injury scores and slowed eGFR decline in patients with chronic active ABMR, without reducing DSAs, suggesting graft-level immune-modulation of fibrosis.
There is a contest called The Shelter Challenge. You click the link and vote - a free way to support rescue.
www.shelterchallenge.com/shelterchall...
ABMR is where I volunteer and how this little guy was saved. They award grants and prizes to further the work we do! Join me daily! #Malinois
www.shelterchallenge.com/shelterchall...
ABMR is where I volunteer and how this little guy was saved. They award grants and prizes to further the work we do! Join me daily! #Malinois
November 15, 2024 at 11:11 AM
There is a contest called The Shelter Challenge. You click the link and vote - a free way to support rescue.
www.shelterchallenge.com/shelterchall...
ABMR is where I volunteer and how this little guy was saved. They award grants and prizes to further the work we do! Join me daily! #Malinois
www.shelterchallenge.com/shelterchall...
ABMR is where I volunteer and how this little guy was saved. They award grants and prizes to further the work we do! Join me daily! #Malinois
#NephJC Earlier with just cyclo, azo and CDC crossmatch many had no rejection. Now despite using all newer tech like DSA and newer drugs we still see ABMR.
October 1, 2025 at 1:38 AM
#NephJC Earlier with just cyclo, azo and CDC crossmatch many had no rejection. Now despite using all newer tech like DSA and newer drugs we still see ABMR.
Antibody-mediated Rejection - Treatment Standard by Drs. Böhmig, Budde et al.
academic.oup.com/ndt/article/...
An expert opinion paper about Treatment Standard by ABMR.
academic.oup.com/ndt/article/...
An expert opinion paper about Treatment Standard by ABMR.
Antibody-mediated Rejection - Treatment Standard
Abstract. Antibody-mediated rejection (AMR) remains a major cause of graft failure, with significant health and economic burden. Despite being recognized &
academic.oup.com
June 4, 2025 at 5:41 PM
Antibody-mediated Rejection - Treatment Standard by Drs. Böhmig, Budde et al.
academic.oup.com/ndt/article/...
An expert opinion paper about Treatment Standard by ABMR.
academic.oup.com/ndt/article/...
An expert opinion paper about Treatment Standard by ABMR.
Bark bark bark abmr bamr bark bamrk brl anrm bark bark asrrruuuuuuuuuu
March 11, 2026 at 6:06 PM
Bark bark bark abmr bamr bark bamrk brl anrm bark bark asrrruuuuuuuuuu
1 retired USAF MWD, 1 ABMR puppy rescue Mal, and HHades, a DOD MWD washout, during his foster. Get a Mal, they said, it will be an adventure …& so it is.
January 8, 2025 at 1:45 AM
1 retired USAF MWD, 1 ABMR puppy rescue Mal, and HHades, a DOD MWD washout, during his foster. Get a Mal, they said, it will be an adventure …& so it is.
Cultural exchange -- Friend sent me two Coldplay music videos, I sent this in return.
www.youtube.com/watch?v=ABMr...
www.youtube.com/watch?v=ABMr...
Ali Deek - Aloush | علي الديك - علوش
YouTube video by Ali Deek
www.youtube.com
November 20, 2024 at 11:08 AM
Cultural exchange -- Friend sent me two Coldplay music videos, I sent this in return.
www.youtube.com/watch?v=ABMr...
www.youtube.com/watch?v=ABMr...
When the Ghost of Micros Past comes to you and tries to convince you to apologize to that rando after you 'accidentally' stepped on them on your way to work...
... but all you can muster up is this kind of energy:
www.youtube.com/watch?v=ABMr...
... but all you can muster up is this kind of energy:
www.youtube.com/watch?v=ABMr...
April 18, 2024 at 6:15 PM
When the Ghost of Micros Past comes to you and tries to convince you to apologize to that rando after you 'accidentally' stepped on them on your way to work...
... but all you can muster up is this kind of energy:
www.youtube.com/watch?v=ABMr...
... but all you can muster up is this kind of energy:
www.youtube.com/watch?v=ABMr...
Die Faschos gabs hier schon immer. Wir hatten das ABMR, bei dem der Prozess 2019 im Chaos scheiterte und nur wenige Meter von dem Ort, wo ich grade sitze schoß 1992 ein Nazi in eine Gruppe Punx & Obdachlose und ermordete Frank Bönisch. Bis heute nicht als Opfer rechter Gewalt anerkannt.
February 25, 2025 at 12:23 PM
Die Faschos gabs hier schon immer. Wir hatten das ABMR, bei dem der Prozess 2019 im Chaos scheiterte und nur wenige Meter von dem Ort, wo ich grade sitze schoß 1992 ein Nazi in eine Gruppe Punx & Obdachlose und ermordete Frank Bönisch. Bis heute nicht als Opfer rechter Gewalt anerkannt.
Previous #NephJC discussion of felzartamab in transplant ABMR here www.nephjc.com/news/felzart... from @kajareeg.bsky.social and @madihaaziz.bsky.social
Playing It Safe: Can Felzartamab Fill the Gap in AMR Treatment? — NephJC
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
www.nephjc.com
June 26, 2025 at 1:58 PM
Previous #NephJC discussion of felzartamab in transplant ABMR here www.nephjc.com/news/felzart... from @kajareeg.bsky.social and @madihaaziz.bsky.social
I did not need to learn of ABMR. I want to bring them all home.
January 8, 2025 at 1:23 PM
I did not need to learn of ABMR. I want to bring them all home.
ENGAGE III survey is live.
Work in transplantation? Your insight on ABMR management can help shape future guidance.
Quick to complete. Real impact.
👉 go.esot.org/engageIII_su...
#ABMR #ClinicalResearch #PoweredByESOT
Work in transplantation? Your insight on ABMR management can help shape future guidance.
Quick to complete. Real impact.
👉 go.esot.org/engageIII_su...
#ABMR #ClinicalResearch #PoweredByESOT
ENGAGE III Survey: Advancing the Management of ABMR in Transplantation
ENGAGE III aims to bring clarity, consistency, and direction to this complex field by providing evidence-based insights and practical guidance for the transplant community.
go.esot.org
May 14, 2026 at 7:00 AM
ENGAGE III survey is live.
Work in transplantation? Your insight on ABMR management can help shape future guidance.
Quick to complete. Real impact.
👉 go.esot.org/engageIII_su...
#ABMR #ClinicalResearch #PoweredByESOT
Work in transplantation? Your insight on ABMR management can help shape future guidance.
Quick to complete. Real impact.
👉 go.esot.org/engageIII_su...
#ABMR #ClinicalResearch #PoweredByESOT
There’s recall/selection bias (you only see the ones who survived on CsA/Aza/Pred)
And
We are doing riskier transplant now than in the past?
And with ABMR always considered nonadherence
#NephJC
And
We are doing riskier transplant now than in the past?
And with ABMR always considered nonadherence
#NephJC
a man in a knight 's armor is laying on a stone wall with flowers on his head .
Alt: a man in a knight 's armor is laying on a stone wall with flowers on his head .
media.tenor.com
October 1, 2025 at 1:43 AM
There’s recall/selection bias (you only see the ones who survived on CsA/Aza/Pred)
And
We are doing riskier transplant now than in the past?
And with ABMR always considered nonadherence
#NephJC
And
We are doing riskier transplant now than in the past?
And with ABMR always considered nonadherence
#NephJC
Chimeric HLA antibody receptor T cell therapy for humoral transplant rejection
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...
Chimeric HLA antibody receptor T cell therapy for humoral transplant rejection
ABSTRACT. Antibody-mediated rejection (ABMR) is a significant obstacle to achieving optimal long-term outcomes after solid organ transplantation. The prese
doi.org
January 23, 2025 at 4:26 PM
Chimeric HLA antibody receptor T cell therapy for humoral transplant rejection
doi.org/10.1093/ndt/...
doi.org/10.1093/ndt/...